DIFFERENCES IN THE MOTOR RESPONSE TO APOMORPHINE BETWEEN UNTREATED AND FLUCTUATING PATIENTS WITH PARKINSONS-DISEASE

被引:34
作者
GRANDAS, F
GANCHER, ST
RODRIGUEZ, M
LERA, G
NUTT, JG
OBESO, JA
机构
[1] CLIN UNIV NAVARRA,DEPT NEUROL,MOVEMENT DISORDERS UNIT,APARTADO 192,E-31080 PAMPLONA,SPAIN
[2] OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201
关键词
APOMORPHINE; UNTREATED PARKINSONS DISEASE; MOTOR FLUCTUATIONS;
D O I
10.1097/00002826-199202000-00002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Behavioral hyposensitivity to repeated apomorphine administration has been observed in fluctuating parkinsonian patients. To investigate whether a similar phenomenon occurs in patients never treated with levodopa, we studied the response to apomorphine in 20 de novo patients with Parkinson's disease. Six patients showed no or minimal improvement after apomorphine injections (maximal dose 3.5 mg). Fourteen patients responded and were then given up to four repeated subcutaneous injections of apomorphine [minimal effective dose (MED)]. The responses of de novo patients were compared with responses in 10 patients with motor fluctuations previously studied by the same protocol. There was no significant difference in latency and duration of motor responses after repeated apomorphine injections in de novo patients. MED was similar in de novo and fluctuating patients, but duration of improvement induced by each apomorphine bolus was longer in the de novo group. These results indicate that response duration to apomorphine is longer in previously untreated patients and that behavioral tolerance associated with pulsatile dopaminergic stimulation by apomorphine occurs mainly in patients with more advanced disease under chronic levodopa therapy.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 17 条
  • [1] INCREASED OR DECREASED LOCOMOTOR RESPONSE IN RATS FOLLOWING REPEATED ADMINISTRATION OF APOMORPHINE DEPENDS ON DOSAGE INTERVAL
    CASTRO, R
    ABREU, P
    CALZADILLA, CH
    RODRIGUEZ, M
    [J]. PSYCHOPHARMACOLOGY, 1985, 85 (03) : 333 - 339
  • [2] CHASE TN, 1989, NEUROLOGY, V39, P7
  • [3] DEJONES GJ, 1987, ANN NEUROL, V422, P4
  • [4] LEVODOPA PHARMACOKINETIC MECHANISMS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
    FABBRINI, G
    JUNCOS, J
    MOURADIAN, MM
    SERRATI, C
    CHASE, TN
    [J]. ANNALS OF NEUROLOGY, 1987, 21 (04) : 370 - 376
  • [5] FAHN S, 1982, MOVEMENT DISORD, P119
  • [6] SUBCUTANEOUS APOMORPHINE IN THE TREATMENT OF PARKINSONS-DISEASE
    FRANKEL, JP
    LEES, AJ
    KEMPSTER, PA
    STERN, GM
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (02) : 96 - 101
  • [7] PERIPHERAL PHARMACOKINETICS OF APOMORPHINE IN HUMANS
    GANCHER, ST
    WOODWARD, WR
    BOUCHER, B
    NUTT, JG
    [J]. ANNALS OF NEUROLOGY, 1989, 26 (02) : 232 - 238
  • [8] DIURNAL RESPONSIVENESS TO APOMORPHINE
    GANCHER, ST
    NUTT, JG
    [J]. NEUROLOGY, 1987, 37 (07) : 1250 - 1253
  • [9] RESPONSE TO BRIEF LEVODOPA INFUSIONS IN PARKINSONIAN-PATIENTS WITH AND WITHOUT MOTOR FLUCTUATIONS
    GANCHER, ST
    NUTT, JG
    WOODWARD, W
    [J]. NEUROLOGY, 1988, 38 (05) : 712 - 716
  • [10] MOTOR RESPONSE FOLLOWING REPEATED APOMORPHINE ADMINISTRATION IS REDUCED IN PARKINSONS-DISEASE
    GRANDAS, F
    OBESO, JA
    [J]. CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) : 14 - 22